Latest News: Independence Realty Trust, Inc., Rexford Industrial Realty (NYSE:REXR), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), RXi Pharmaceuticals Corporation (NASDAQ:RXII)


Harvest Natural Resources Inc. (NYSE:HNR) shares fell -4.62% in last trading session and ended the day at $0.62. HNR has a return on assets of -88.00%. Harvest Natural Resources Inc. (NYSE:HNR) quarterly performance is -46.55%.

Independence Realty Trust, Inc. (NYSEMKT:IRT) ended the last trading day at $6.72. Company weekly volatility is calculated as 3.74% and price to cash ratio as 18.71. Independence Realty Trust, Inc. (NYSEMKT:IRT) showed a weekly performance of -2.18%.

Independence Realty Trust, Inc. (NYSE MKT: IRT) (“IRT”) announced that, on January 14, 2016, IRT’s Board of Directors declared monthly cash dividends for the first quarter of 2016 on IRT’s shares of common stock in the amount of $0.06 per share per month. The monthly dividends total $0.18 per share for the first quarter. The dividend of January will be payable on 2 February, n the record date of 29 January, 2016

On 27 January, Rexford Industrial Realty, Inc. (NYSE:REXR) shares fell -2.60% and was closed at $15.76. Rexford Industrial Realty, Inc. (NYSE:REXR) year to date (YTD) performance is -3.67%.

Zacks Investment Research cut shares of Rexford Industrial Realty Inc (NYSE:REXR) from a hold rating to a sell rating in a research note issued to investors on Monday, Analyst Ratings.Net reports.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares fell -7.46% in last trading session and ended the day at $21.95. ACAD has a return on assets of -51.20%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) quarterly performance is -34.40%.

On 25 January, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the appointment of , M.D., as Senior Vice President, Clinical Development and Chief Medical Officer. Dr. Owen will be responsible for evolving and executing the clinical development programs for ACADIA’s product candidates and report to , M.D., M.S.P.H., ACADIA’s Executive Vice President, Head of Research and Development.

RXi Pharmaceuticals Corporation (NASDAQ:RXII) caters to the Healthcare space. Its weekly performance is 6.14%. On the last day of trading company shares ended up at $0.30. RXi Pharmaceuticals Corporation (NASDAQ:RXII) distance from 50-day simple moving average (SMA50) is -18.41%.

RXi Pharmaceuticals Corporation (NASDAQ:RXII) announced that the Company’s President and CEO, Dr. Geert Cauwenbergh, will present at the 18th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2016 at 2:30 p.m. ET in New York City.


Leave a Reply

Your email address will not be published. Required fields are marked *